2m 2m 2m 2m 2m 2m 2m
AVITA Medical (RCEL)
NASDAQ
$4.25+$0.06 (+1.48%)
Price as of Jun 03, 2026 7:55 PM EDT- $133.3MMarket Cap
- -28.50%1-Year Change
- Medical DevicesIndustry
AVITA Medical (RCEL)
$4.25+$0.06 (+1.48%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 71.6M +11.45% | 64.3M +28.14% | 50.1M +45.68% | 34.4M +146.64% | |
Cost of Revenue | 12.8M +40.69% | 9.1M +16.89% | 7.8M +28.79% | 6.0M +217.11% | |
Gross Profit | 58.8M +6.63% | 55.2M +30.20% | 42.4M +49.27% | 28.4M +135.50% | |
Sales and Marketing Expense | 53.1M -8.69% | 58.2M +56.06% | 37.3M +70.18% | 21.9M +158.65% | |
Research and Development Expense | -20.8M +2.35% | -20.4M -2.21% | -20.8M +50.26% | -13.9M +82.67% | |
Depreciation and Amortization Expense | 2.3M +108.44% | 1.1M +78.16% | 632,000 +11.27% | 568,000 +72.12% | |
Total Operating Expenses | 101.3M -9.31% | 111.8M +29.27% | 86.4M +46.27% | 59.1M +118.45% | |
Operating Profit | -42.5M -24.84% | -56.6M +32.68% | -42.7M +55.08% | -27.5M +90.70% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 892,000 +2,247.37% | |
Interest Expense | -5.0M -6.66% | -5.4M +369.03% | -1.1M +7,043.75% | -16,000 -5.88% | |
Interest Income and Expense and Net | -5.0M -6.66% | -5.4M +369.03% | -1.1M -230.48% | 876,000 +4,071.43% | |
Total Nonoperating Income and Expense | -1.0M -736.81% | 163,000 -98.08% | 8.5M +851.01% | 892,000 +2,247.37% | |
Income before Taxes | -48.6M -21.39% | -61.8M +74.97% | -35.3M +32.62% | -26.6M +84.90% | |
Income Taxes | 11,000 -79.63% | 54,000 -18.18% | 66,000 +83.33% | 36,000 +44.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -48.6M -21.44% | -61.8M +74.80% | -35.4M +32.69% | -26.7M +84.83% | |
Net Income from Continuing Operations Applicable to Common | -48.6M -21.39% | -61.8M +74.97% | -35.3M +32.62% | -26.6M +84.90% | |
Basic EPS and Net Income | -1.74 -27.20% | -2.39 -270.71% | 1.40 +30.84% | 1.07 +84.48% | |
Diluted EPS and Net Income | -1.74 -27.20% | -2.39 -270.71% | 1.40 +30.84% | 1.07 +84.48% | |
Basic Weighted Average Shares | 27.9M +7.64% | 25.9M +2.18% | 25.3M +1.32% | 25.0M +0.34% | |
Diluted Weighted Average Shares | 27.9M +7.64% | 25.9M +2.18% | 25.3M +1.32% | 25.0M +0.34% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 10.2M -27.10% | 14.1M -36.48% | 22.1M +21.77% | 18.2M -67.28% | |
Short-Term Investments | 7.9M -63.63% | 21.8M -67.38% | 66.9M +9.42% | 61.2M +106.34% | |
Cash and Cash Equivalents and Short-Term Investments | 18.2M -49.32% | 35.9M -59.71% | 89.1M +12.24% | 79.3M -6.83% | |
Total Current Assets | 35.5M -37.74% | 57.0M -45.20% | 104.0M +18.92% | 87.5M -5.07% | |
Accumulated Depreciation | 5.1M +48.10% | 3.4M +41.74% | 2.4M +13.01% | 2.2M +26.96% | |
Property and Plant and Equipment and Net | 8.6M -13.86% | 10.0M +433.72% | 1.9M +56.42% | 1.2M -4.91% | |
Total Long-Term Assets | 612,000 +12.09% | 546,000 +53.80% | 355,000 +190.98% | 122,000 -87.05% | |
Total Assets | 56.4M -29.25% | 79.7M -28.60% | 111.6M +13.61% | 98.3M -15.30% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 43.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 62.7M +210.93% | 20.2M +52.72% | 13.2M +23.44% | 10.7M +16.91% | |
Total Long-Term Debt | 0 -100.00% | 42.2M +6.11% | 39.8M N/A | N/A N/A | |
Total Long-Term Liabilities | 2.4M -95.03% | 48.8M +8.47% | 45.0M +39,748.67% | 113,000 -69.87% | |
Total Liabilities | 73.0M -2.57% | 75.0M +21.13% | 61.9M +377.30% | 13.0M +13.84% | |
Retained Earnings | -408.4M +13.50% | -359.8M +20.76% | -298.0M +13.47% | -262.6M +11.30% | |
Total Stockholders Equity | -16.6M -470.08% | 4.5M -90.83% | 49.1M -42.11% | 84.7M -19.01% | |
Total Shares Outstanding | 30.6M +16.00% | 26.4M +2.62% | 25.7M +1.88% | 25.2M +1.13% | |
Cash Flow | |||||
Cash from Operating Activities | -31.2M -36.26% | -48.9M +28.75% | -38.0M +99.11% | -19.1M +247.03% | |
Capital Expenditures | 1.0M -89.04% | 9.2M +564.08% | 1.4M +205.53% | 452,000 +595.38% | |
Cash from Investing Activities | 12.5M -66.67% | 37.4M +2,225.02% | 1.6M +108.31% | -19.3M -61.09% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 14.9M +325.77% | 3.5M -91.31% | 40.4M +4,386.00% | 900,000 +12,757.14% | |
Financials Ratio | |||||
Gross Margin | 82.13% -4.32% | 85.85% +1.61% | 84.48% +2.47% | 82.45% -4.52% | |
Operating Margin | -59.40% -32.57% | -88.08% +3.54% | -85.07% +6.46% | -79.91% -22.68% | |
Return on Assets | -71.40% +10.45% | -64.64% +91.75% | -33.71% +35.45% | -24.89% +71.20% | |
Return on Equity | 799.72% +446.26% | -230.96% +336.69% | -52.89% +87.79% | -28.16% +72.78% | |
Revenue Growth | 11.45% -59.29% | 28.14% -38.40% | 45.68% -68.85% | 146.64% +6,912.83% | |
Current Ratio | 0.57 -79.98% | 2.83 -64.11% | 7.88 -3.66% | 8.18 -18.81% | |
Cash Ratio | 0.16 -76.56% | 0.70 -58.41% | 1.68 -1.35% | 1.70 -72.01% | |
Debt-to-Equity Ratio | -2.58 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.76 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow